AAAAAA
Results:
1-14
|
Results: 14
Authors:
Casale, TB
Nelson, HS
Corren, J
Newman, K
Citation: Tb. Casale et al., Long-term safety of flunisolide hydrofluoroalkane metered-dose inhaler in adults and adolescents with asthma, CLIN DRUG I, 21(11), 2001, pp. 755-764
Authors:
Corren, J
Nelson, H
Greos, LS
Bensch, G
Goldstein, M
Wu, J
Wang, SS
Newman, K
Citation: J. Corren et al., Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients, ANN ALLER A, 87(5), 2001, pp. 405-411
Authors:
Corren, J
Spector, S
Fuller, L
Minkwitz, M
Mezzanotte, W
Citation: J. Corren et al., Effects of zafirlukast upon clinical, physiologic, and inflammatory responses to natural cat allergen exposure, ANN ALLER A, 87(3), 2001, pp. 211-217
Authors:
Busse, W
Corren, J
Lanier, BQ
McAlary, M
Fowler-Taylor, A
Della Cioppa, G
van As, A
Gupta, N
Citation: W. Busse et al., Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma, J ALLERG CL, 108(2), 2001, pp. 184-190
Authors:
Borish, LC
Nelson, HS
Corren, J
Bensch, G
Busse, WW
Whitmore, JB
Agosti, JM
Citation: Lc. Borish et al., Efficacy of soluble IL-4 receptor for the treatment of adults with asthma, J ALLERG CL, 107(6), 2001, pp. 963-970
Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma
Authors:
Nayak, AS
Banov, C
Corren, J
Feinstein, BK
Floreani, A
Friedman, BF
Goldsobel, A
Gottschlich, GM
Hannaway, PJ
Lampl, KL
Lapidus, RJ
Lawrence, M
Lumry, W
Munk, Z
Pearlman, D
Scardella, AT
Schenkel, EJ
Segal, AT
Segall, N
Silverman, B
Shneyer, L
Nolop, KB
Harrison, JE
Citation: As. Nayak et al., Once-daily mometasone furoate dry powder inhaler in the treatment of patients with persistent asthma, ANN ALLER A, 84(4), 2000, pp. 417-424
Authors:
Corren, J
Citation: J. Corren, The link between allergic rhinitis and asthma, otitis media, sinusitis, and nasal polyps, IMMUNOL ALL, 20(2), 2000, pp. 445
Authors:
Geha, RS
Beiser, A
Ren, C
Patterson, R
Greenberger, PA
Grammer, LC
Ditto, AM
Harris, KE
Shaughnessy, MA
Yarnold, PR
Corren, J
Saxon, A
Citation: Rs. Geha et al., Multicenter, double-blind, placebo-controlled, multiple-challenge evaluation of reported reactions to monosodium glutamate, J ALLERG CL, 106(5), 2000, pp. 973-980
Authors:
Corren, J
Citation: J. Corren, Allergic rhinitis: Treating the adult, J ALLERG CL, 105(6), 2000, pp. S610-S615
Authors:
Corren, J
Citation: J. Corren, The association between allergic rhinitis and asthma in children and adolescents: Epidemiologic considerations, PEDIAT ANN, 29(7), 2000, pp. 400
Authors:
Geha, RS
Beiser, A
Ren, C
Patterson, R
Greenberger, PA
Grammer, LC
Ditto, AM
Harris, KE
Shaughnessy, MA
Yarnold, PR
Corren, J
Saxon, A
Citation: Rs. Geha et al., Review of alleged reaction to monosodium glutamate and outcome of a multicenter double-blind placebo-controlled study, J NUTR, 130(4), 2000, pp. 1058S-1062S
Authors:
Corren, J
Rachelefsky, G
Citation: J. Corren et G. Rachelefsky, Sinusitis and otitis media, CUR CL PRAC, 2000, pp. 183-193
Authors:
Corren, J
Citation: J. Corren, Intranasal corticosteroids for allergic rhinitis: How do different agents compare?, J ALLERG CL, 104(4), 1999, pp. S144-S149
Authors:
Corren, J
Rachelefsky, G
Spector, S
Schanker, H
Siegel, S
Holton, D
Karcher, K
Travers, S
Citation: J. Corren et al., Onset and duration of action of levocabastine nasal spray in atopic patients under nasal challenge conditions, J ALLERG CL, 103(4), 1999, pp. 574-580
Risultati:
1-14
|